Camden, NJNCT07439172Now EnrollingIRB Ready

High Grade Gliomas Clinical Trial in Camden, NJ

Access cutting-edge high grade gliomas treatment through this phase 2 clinical trial at a research site in Camden. Study-provided care at no cost to qualified participants.

Sponsored by The Cooper Health System

Quick Self-Assessment

See if you qualify for this Camden location

Preparing your pre-screening questions…

Expert Care in Camden

Access high grade gliomas specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related high grade gliomas treatment provided free

Apply for This Camden Location

Check if you qualify for this high grade gliomas clinical trial in Camden, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Camden

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Camden site if eligible
  4. 4Begin participation

About This High Grade Gliomas Study in Camden

Better treatments are needed for high-grade gliomas (HGG), and new ways of treating this disease should be tested. The investigators want to see if giving medicine before radiation works well. After radiation, MRI scans can be harder to understand because radiation changes how the brain looks on the scan. If new medicines are given before radiation, the scans are easier to read. First, the investigators need to find out if giving chemotherapy early works using a drug we already know can treat gliomas. The investigators will start with temozolomide, which is the only chemotherapy approved by the FDA for HGG. If this approach is successful, the investigators can then test new drugs using this screening method.

Sponsor: The Cooper Health System

Who Can Participate

Inclusion Criteria

Pathologic diagnosis of high-grade glioma
Residual measurable post-operative contrast enhancing tumor
Lack of urgency in requiring immediate radiation or chemotherapy (mass effect, mid-line shift, herniation, etc.)
Ability to provide informed consent
Willingness to comply with all study procedures and availability for the duration of the study
Male or female, aged 18-80.
Karnofsky Performance Status ³70%.
Patients must have the following organ and marrow functions: Absolute neutrophil count ≥1,500/µL Platelets ≥100,000/µL Hemoglobin ≥ 9 g/dL Total bilirubin £ 1.5 × institutional upper limit of normal (ULN), (except for patients with known Gilbert's syndrome who must have normal direct bilirubin) AST (SGOT)/ALT (SGPT) £ 2.5 × ULN Creatinine £ 1.5 × ULN OR Creatinine clearance ≥ 60 mL/min/1.73m2 APTT/PTT ≤ 1.5 × ULN Sodium ≥ the institutional lower limit of normal
Ability to take oral medication and be willing to adhere to the pre-radiation temozolomide regimen
For females of reproductive potential: use of highly effective contraception for at least 1 week prior to screening and agreement to use such a method during study participation and for an additional 4 weeks after the end of pr-radiation temozolomide administration
For males of reproductive potential: use of condoms or other methods to ensure effective contraception with partner
Patients must have measurable disease as defined by RANO criteria.

Exclusion Criteria

Patients receiving any other investigational agents are ineligible.
Patients who had Gliadel wafer or other local therapy placed in the tumor cavity during the tumor resection.
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to TMZ are ineligible.
Patients with uncontrolled intercurrent illness including, but not limited to, ongoing or active infection or psychiatric illness/social situations that would limit compliance with study requirements, are ineligible.
Pregnant women are excluded from this study because TMZ has potential for teratogenic or abortifacients effects. Breastfeeding should be discontinued if the mother is treated with TMZ.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Camden?

Yes, this clinical trial (NCT07439172) has an active research site in Camden, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

High Grade Gliomas Treatment Options in Camden, NJ

If you're searching for high grade gliomas treatment options in Camden, NJ, this clinical trial (NCT07439172) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Camden research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced high grade gliomas specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all high grade gliomas clinical trials near you to find additional studies recruiting in your area.

More Brain Cancer Trials in Camden, NJ

See all brain cancer clinical trials recruiting in Camden — not just this study.

Browse Brain Cancer Trials in Camden →

Browse More Trials by Condition

Brain Cancer TrialsAlzheimers Disease TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Camden?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Camden, NJ